Wird geladen...
Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
Provision of high-level healthcare is a challenge for all low- to middle-income countries (LMICs) since healthcare systems are heterogeneous, face many challenges such as inadequate funding, inequitable distribution of resources and services and usually are not adequately equipped to deal with a hug...
Gespeichert in:
| Veröffentlicht in: | Ecancermedicalscience |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cancer Intelligence
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6372298/ https://ncbi.nlm.nih.gov/pubmed/30792815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2019.898 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|